• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童黑色素瘤发病和生存情况:韩国一项十五年全国回顾性队列研究。

Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea.

机构信息

Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Bundang-gu, Gyeonggi-do.

Division of Hemato-Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Giheung-gu, Yongin-si.

出版信息

Melanoma Res. 2024 Dec 1;34(6):528-534. doi: 10.1097/CMR.0000000000001000. Epub 2024 Aug 30.

DOI:10.1097/CMR.0000000000001000
PMID:39206815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11524617/
Abstract

The aim of this study was to explore the epidemiology of cutaneous malignant melanoma (CMM) and the associated risk factors influencing its occurrence and survival among Koreans aged <20 years. In this retrospective cohort investigation, we identified cases of incident melanoma diagnosed in Korean patients aged 0-19 years between 2004 and 2019, utilizing the National Health Insurance database. We assessed annual fluctuations in age-adjusted incidence rates and examined 5-year survival rates based on various factors, including sex, age, income level, sun-exposed sites, and the Charlson Comorbidity Index. Of 1160 patients, 51.4% were male and 48.6% were female. The mean age of the patients was 11 years, mostly belonging to the top 25% high-income group. The head and neck regions were the most frequently affected sites. The overall age-adjusted incidence rate of melanoma was 0.22 per 100,000 persons. This rate witnessed a decline of 4.5% annually from 2004 to 2012, followed by a subsequent increase of 12.6% annually from 2012 to 2019. Notably, patients with CMM in low-sun-exposed sites exhibited poorer survival rates compared with those in high-sun-exposed areas ( P  < 0.05). The incidence of melanomas in children and adolescents in Korea has shown a rising trend since 2012. Further research is needed to investigate the etiology and risk factors in pediatric patients.

摘要

本研究旨在探讨韩国 20 岁以下人群皮肤恶性黑色素瘤(CMM)的流行病学特征,以及影响其发病和生存的相关危险因素。在这项回顾性队列研究中,我们利用国家健康保险数据库,确定了 2004 年至 2019 年期间韩国 0-19 岁患者的新发黑色素瘤病例。我们评估了年龄调整发病率的年度波动,并根据性别、年龄、收入水平、阳光暴露部位和 Charlson 合并症指数等因素,检查了 5 年生存率。在 1160 名患者中,51.4%为男性,48.6%为女性。患者的平均年龄为 11 岁,主要属于收入最高的前 25%群体。头颈部是最常受影响的部位。黑色素瘤的总体年龄调整发病率为 0.22/10 万人。该发病率从 2004 年至 2012 年每年下降 4.5%,然后从 2012 年至 2019 年每年增加 12.6%。值得注意的是,低阳光暴露部位的 CMM 患者的生存率低于高阳光暴露部位的患者(P<0.05)。自 2012 年以来,韩国儿童和青少年黑色素瘤的发病率呈上升趋势。需要进一步研究以调查儿科患者的病因和危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/299b8124fdf9/mr-34-528-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/6964bd2ca07f/mr-34-528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/ceb24a02dde2/mr-34-528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/299b8124fdf9/mr-34-528-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/6964bd2ca07f/mr-34-528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/ceb24a02dde2/mr-34-528-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8038/11524617/299b8124fdf9/mr-34-528-g003.jpg

相似文献

1
Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea.儿童黑色素瘤发病和生存情况:韩国一项十五年全国回顾性队列研究。
Melanoma Res. 2024 Dec 1;34(6):528-534. doi: 10.1097/CMR.0000000000001000. Epub 2024 Aug 30.
2
Epidemiology of cutaneous melanoma and melanoma in situ: a 10-year nationwide retrospective cohort study in South Korea.皮肤黑色素瘤和原位黑色素瘤的流行病学:韩国一项为期 10 年的全国回顾性队列研究。
Melanoma Res. 2020 Jun;30(3):297-302. doi: 10.1097/CMR.0000000000000547.
3
Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.加拿大皮肤恶性黑色素瘤病例的发病率、死亡率和时空分布。
J Cutan Med Surg. 2019 Jul/Aug;23(4):394-412. doi: 10.1177/1203475419852048. Epub 2019 May 27.
4
Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.利用全国健康保险索赔数据评估韩国皮肤黑色素瘤的发病率和生存率。
Cancer Res Treat. 2022 Jul;54(3):937-949. doi: 10.4143/crt.2021.871. Epub 2021 Sep 30.
5
Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.中欧恶性黑色素瘤的流行病学:风险因素与预后预测指标。德国皮肤病学会中央恶性黑色素瘤登记处的结果。
Pigment Cell Res. 1992;Suppl 2:285-94. doi: 10.1111/j.1600-0749.1990.tb00387.x.
6
Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study.韩国巨大多发性先天性黑素细胞痣患者的临床特征和黑素瘤发病风险:一项全国性回顾性研究。
Br J Dermatol. 2012 Jan;166(1):115-23. doi: 10.1111/j.1365-2133.2011.10636.x.
7
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.欧洲恶性黏膜和葡萄膜黑色素瘤及附属器皮肤癌的描述性流行病学。
Eur J Cancer. 2012 May;48(8):1167-75. doi: 10.1016/j.ejca.2011.10.004. Epub 2011 Nov 25.
8
Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.2000-2009 年哥伦比亚人群中皮肤恶性黑色素瘤的基于人群的发病率和黑色素瘤特异性生存率。
Int J Dermatol. 2018 Jan;57(1):21-27. doi: 10.1111/ijd.13839. Epub 2017 Dec 12.
9
Age-Specific Incidence of Melanoma in the United States.美国特定年龄段的黑色素瘤发病率。
JAMA Dermatol. 2020 Jan 1;156(1):57-64. doi: 10.1001/jamadermatol.2019.3353.
10
Trends in cutaneous malignant melanoma incidence, mortality and survival over three decades: a population-based study in Southern Spain.三十年间皮肤恶性黑色素瘤的发病率、死亡率及生存率趋势:西班牙南部一项基于人群的研究
Clin Exp Dermatol. 2025 Apr 24;50(5):981-993. doi: 10.1093/ced/llae516.

本文引用的文献

1
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes.儿童和青少年黑色素瘤:临床病理特征与生存结果
J Am Acad Dermatol. 2023 Mar;88(3):609-616. doi: 10.1016/j.jaad.2022.08.067. Epub 2022 Dec 9.
2
Increased incidence of melanoma in children and adolescents in Finland in 1990-2014: nationwide re-evaluation of histopathological characteristics.1990-2014 年芬兰儿童和青少年黑色素瘤发病率上升:对组织病理学特征的全国性再评估。
Ann Med. 2022 Dec;54(1):244-252. doi: 10.1080/07853890.2022.2026001.
3
Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.
利用全国健康保险索赔数据评估韩国皮肤黑色素瘤的发病率和生存率。
Cancer Res Treat. 2022 Jul;54(3):937-949. doi: 10.4143/crt.2021.871. Epub 2021 Sep 30.
4
Age-Specific Incidence of Melanoma in the United States.美国特定年龄段的黑色素瘤发病率。
JAMA Dermatol. 2020 Jan 1;156(1):57-64. doi: 10.1001/jamadermatol.2019.3353.
5
Comorbidity Index as a Predictor of Mortality in Pediatric Patients With Solid Tumors.合并症指数作为实体瘤儿科患者死亡率的预测指标
Front Pediatr. 2019 Mar 1;7:48. doi: 10.3389/fped.2019.00048. eCollection 2019.
6
Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.队列简介:韩国国民健康保险服务国家样本队列(NHIS-NSC)
Int J Epidemiol. 2017 Apr 1;46(2):e15. doi: 10.1093/ije/dyv319.
7
Melanoma Incidence in Children and Adolescents: Decreasing Trends in the United States.儿童和青少年黑色素瘤发病率:美国呈下降趋势
J Pediatr. 2015 Jun;166(6):1505-13. doi: 10.1016/j.jpeds.2015.02.050. Epub 2015 Apr 9.
8
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.《1975-2009 年全国癌症报告:人乳头瘤病毒(HPV)相关癌症的负担和趋势以及 HPV 疫苗接种覆盖率》
J Natl Cancer Inst. 2013 Feb 6;105(3):175-201. doi: 10.1093/jnci/djs491. Epub 2013 Jan 7.
9
Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.先前患癌后诊断出的皮肤黑色素瘤的风险与生存率
Arch Dermatol. 2011 Dec;147(12):1395-402. doi: 10.1001/archdermatol.2011.1133.
10
Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.监测、流行病学和最终结果(SEER)计划中头皮或颈部黑色素瘤患者与其他部位黑色素瘤患者的生存差异。
Arch Dermatol. 2008 Apr;144(4):515-21. doi: 10.1001/archderm.144.4.515.